Clinical Trials Directory

Trials / Conditions / Childhood Acute Monoblastic Leukemia (M5a)

Childhood Acute Monoblastic Leukemia (M5a)

11 registered clinical trials studyying Childhood Acute Monoblastic Leukemia (M5a).

StatusTrialSponsorPhase
TerminatedDonor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
NCT01801046
University of Southern CaliforniaPhase 1
CompletedStudying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
NCT01642121
Children's Oncology Group—
CompletedBiomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
NCT01076569
Children's Oncology Group—
CompletedIdentification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT01146210
Children's Oncology Group—
CompletedBortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary
NCT00666588
National Cancer Institute (NCI)Phase 2
CompletedDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01093586
Case Comprehensive Cancer CenterPhase 2
CompletedCombination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysp
NCT00369317
Children's Oncology GroupPhase 3
TerminatedIdarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid
NCT00096148
National Cancer Institute (NCI)Phase 2
CompletedCombination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 i
NCT00006363
National Cancer Institute (NCI)Phase 3
CompletedCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogeno
NCT00002798
National Cancer Institute (NCI)Phase 3
CompletedHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patient
NCT01177371
Case Comprehensive Cancer CenterPhase 2